Sinotrans' healthy 3Q22 suggested profitability remains solid and it is recovering well from the challenges in 2Q22. Consensus is too low, net cash position and high ROE all say valuations are cheap.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.